| Database ID | Agent | Target | Cancer Type | Detail |
| DB00541 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | ovarian cancer | view |
| DB00542 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | ovarian, primary peritoneal carcinoma | view |
| DB00543 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | ovarian carcinoma or primary peritoneal carcinoma | view |
| DB00544 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | ovarian carcinoma or primary peritoneal carcinoma | view |
| DB00545 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | ovarian carcinoma or primary peritoneal carcinoma | view |
| DB00546 | sorafenib | Vascular endothelial growth factor receptor 1
BRaf protooncogene serine/threonineprotein kinase
Protooncogene tyrosineprotein kinase receptor ret | ovarian cancer | view |
| DB00547 | MPDL3280A | Programmed cell death ligand 1 (PDL1) | bladder cancer | view |
| DB00548 | bevacizumab | Vascular endothelial growth factor | Urothelial Carcinoma | view |
| DB00549 | temsirolimus | Serine/threonineprotein kinase mTOR | Urothelial Carcinoma | view |
| DB00550 | everolimus | Serine/threonineprotein kinase mTOR | Urothelial Carcinoma | view |
| DB00551 | everolimus | Serine/threonineprotein kinase mTOR | Urothelial Carcinoma | view |
| DB00552 | Cetuximab | Epidermal growth factor receptor | Urothelial Carcinoma | view |
| DB00553 | Cetuximab | Epidermal growth factor receptor | Urothelial Carcinoma | view |
| DB00554 | erlotinib | Epidermal growth factor receptor | bladder cancer | view |
| DB00555 | lapatinib | Epidermal growth factor receptor
Receptor proteintyrosine kinase erbB2 | Urothelial Carcinoma | view |